Aquestive Therapeutics, Inc. Common Stock

AQSTNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
3.93 USD
↘ 0.21 (5.07%)AT CLOSE (11:59 AM EDT)
3.95
↗ 0.02 (0.51%)
POST MARKET (AS OF 06:56 PM EDT)
Post Market
AS OF 06:56 PM EDT
3.95
↗ 0.02 (0.51%)
🔴Market: CLOSED
Open?$4.14
High?$4.16
Low?$3.92
Prev. Close?$4.14
Volume?1.2M
Avg. Volume?1.6M
VWAP?$4.03
Rel. Volume?0.76x
Bid / Ask
Bid?$3.41 × 100
Ask?$4.54 × 100
Spread?$1.13
Midpoint?$3.98
Valuation & Ratios
Market Cap?493.0M
Shares Out?125.5M
Float?100.0M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?-14.48
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A

Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $3.93. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (202.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
147
Market Cap
493.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.aquestive.com
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
83
Short Sent.?
25
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.01Distress
Confidence?51%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?15.04%High
Short Interest?15.0M
Days to Cover?7.4
Free Float100.0M
Avg Daily Volume2.0M
Settlement Date2026-05-15
Financial Health
Current Ratio?4.10Strong
Quick Ratio?3.85Strong
Cash Ratio?3.49Strong
Debt/Equity?-1.14Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-14.48CHEAP▾
P/S?
Peers
100
S&P
8
9.81HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-7.2CHEAP▾
EV/Sales?
Peers
100
S&P
16
8.38HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
202.4%STRONG▾
ROA?
S&P
3
-48.8%WEAK▾
Cash Flow & Enterprise
FCF?$-44317000
Enterprise Value?$421.0M
Fundamentals ratios updated end of day
MarketsMoversWatchlist